市場調查報告書
商品編碼
1541244
2024-2032年按材料(聚氯乙烯、聚丙烯、工程塑膠、聚乙烯、聚苯乙烯、有機矽等)、應用和地區分類的醫用塑膠市場報告Medical Plastics Market Report by Material (Polyvinyl Chloride, Polypropylene, Engineering Plastics, Polyethylene, Polystyrene, Silicones, and Others), Application, and Region 2024-2032 |
IMARC Group年全球醫用塑膠市場規模達277億美元。對醫療器材和設備的需求不斷增加、慢性病盛行率不斷上升、嚴格的監管標準、老年人口不斷增加、強調感染預防的COVID-19 大流行、技術進步和微創外科(MIS) 程序是創造積極前景的一些因素為市場。
主要市場促進因素:醫用塑膠市場佔有率主要得益於全球醫療保健基礎設施投資的快速成長,這進一步推動了對防護性醫療設備的高需求,從而增加了醫用塑膠的使用。與此一致,已開發國家人口老化需要更多的醫療關注,這導致用於製造醫療器材和包裝的醫用塑膠消耗更多,進一步加速醫用塑膠市場的成長。根據醫用塑膠市場的最新發展,醫療產業的技術突破以及更多設備一次性使用的趨勢增加了對特種塑膠的需求,進一步支持了醫用塑膠市場的需求。此外,家庭醫療服務和遠距醫療的興起增加了塑膠零件的產量,這進一步推動了醫用塑膠市場的前景。此外,由於衛生標準高,醫療設施中使用的大多數設備都是由塑膠製成,因為該材料易於消毒和無菌,這支持了醫用塑膠市場的預測。
主要市場趨勢:醫用塑膠市場的主要趨勢包括擴大採用高性能塑膠,因為它們具有高耐化學性、耐熱性和耐衝擊性。高性能塑膠之所以顯得時尚,是因為大多數醫療設備和其他產品對於診所或醫院的外科手術和其他工作都是不可或缺的。與此一致,相容醫療設備和植入物的3D(3D)列印的採用增加了對此類設備的需求,這進一步推動了醫用塑膠市場的收入。根據醫用塑膠市場報告,3D 技術現已成為人們訂購所需設備的客製化方式之一。
地理趨勢:從醫用塑膠市場概況來看,北美地區在全球醫用塑膠市場中佔據領先地位。這一趨勢源於發達的醫療保健基礎設施、對醫療技術的大量投資以及為醫用塑膠製定高品質標準的嚴格監管。根據醫用塑膠市場分析,該地區對醫療保健領域獨特解決方案(例如穿戴式設備和遠距醫療)的關注刺激了先進醫用塑膠的使用。北美強大的製藥行業要求包裝的安全性和質量,這為增加醫用級塑膠的應用創造了條件。
競爭格局:根據醫用塑膠市場統計數據,醫用塑膠市場的一些主要參與者包括阿科瑪公司、巴斯夫、塞拉尼斯公司、科思創公司、陶氏化學公司、杜邦公司、贏創工業公司、埃克森美孚美孚公司、SABIC、索爾維公司、路博潤公司(伯克希爾哈撒韋公司)、Trinseo PLC 等。
挑戰與機會:醫用塑膠市場面臨多項挑戰,包括遵守嚴格監管標準的高成本,這可能會抑制產品開發和市場進入的速度。此外,不可生物分解塑膠對環境的影響構成了挑戰,迫使製造商創新更永續的解決方案。然而,這些挑戰也為醫用塑膠市場帶來了近期的機會。人們對先進、環保的醫用塑膠的需求不斷成長,這些塑膠的性能與傳統材料相同或更好。發展中經濟體也存在機會,這些經濟體不斷擴大的醫療基礎設施需要增加醫用塑膠的數量,這進一步加速了醫用塑膠市場近期的價格上漲。
醫療器材需求不斷增加
世界各地對醫療器材和設備的需求不斷成長,是全球醫用塑膠市場的關鍵成長因素。相對價格實惠且符合醫療產品嚴格的監管規範。從診斷設備到手術器械,醫用級塑膠用途廣泛,足以適應各種應用。
慢性病盛行率激增
造成這一趨勢的另一個主要因素是慢性病的快速增加,從糖尿病、心血管疾病到呼吸系統疾病。由於此類疾病的盛行率不斷增加,全球對醫療介入和治療的需求很高。因此,需要各種由塑膠製成的醫療設備、工具和產品來滿足這種不斷成長的需求,這進一步增加了對醫用塑膠的需求,因為它們耐用、靈活且具有生物相容性,使其非常適合疾病的多種應用控制和管理。
嚴格的監管標準
對醫療器材和產品安全性和功效的嚴格監管標準也推動了對醫用塑膠的需求。全球監管機構為醫療保健應用中使用的材料提供指南,以確保它們具有高品質且對患者健康安全。醫用級塑膠具有生物相容性、無菌性和耐化學性等特性,符合法規要求。因此,隨著病患安全和感染控制受到醫療機構前所未有的重視,許多人更喜歡由優質塑膠製成的醫療設備和裝置來支持這些優先事項。
IMARC Group提供了每個細分市場的主要趨勢分析,以及 2024-2032 年全球、區域和國家層面的預測。我們的報告根據材料和應用對市場進行了分類。
聚氯乙烯 (PVC)
聚丙烯(PP)
工程塑膠
聚乙烯(PE)
聚苯乙烯(PS)
有機矽
其他
聚氯乙烯 (PVC) 代表領先的細分市場
該報告根據材料提供了詳細的市場細分和分析。這包括聚氯乙烯 (PVC)、聚丙烯 (PP)、工程塑膠、聚乙烯 (PE)、聚苯乙烯 (PS)、有機矽等。報告稱,聚氯乙烯(PVC)是最大的市場區隔。
醫用塑膠中的聚氯乙烯 (PVC) 領域受到幾個關鍵因素的推動,例如醫療器材製造中對具有成本效益和多功能材料的需求不斷增加,推動了 PVC 使用量的成長。 PVC 在經濟性和性能之間實現了平衡,使其成為各種醫療應用(例如導管、靜脈注射 (IV) 袋和輸血器)的有吸引力的選擇。此外,PVC 的優異性能(包括柔韌性、耐用性和耐化學性)使其適用於各種醫療器材和設備,推動其在醫療保健環境中的採用。此外,嚴格的監管標準要求在醫療應用中使用安全和無菌材料,這進一步增加了對 PVC 的需求,因為它有效地滿足了監管要求。此外,PVC 的多功能性使製造商能夠根據特定的醫療保健需求生產各種醫療產品,以滿足不同的患者群體和醫療程序。除此之外,COVID-19 大流行凸顯了 PVC 在醫療保健領域的重要性,特別是在個人防護裝備套件和醫療包裝等基本醫療用品的生產中,進一步推動了其需求。
免洗用品
藥物輸送裝置
診斷儀器
導管
手術器械
其他
一次性用品代表了領先的細分市場
該報告根據應用程式提供了詳細的市場細分和分析。這包括一次性用品、藥物輸送裝置、診斷儀器、導管、手術器械等。根據該報告,一次性用品佔最大部分。
醫用塑膠的一次性用品市場受到幾個關鍵因素的推動,每個因素都對其成長軌跡產生重大影響,例如醫療保健環境中對一次性醫療產品的需求不斷增加,推動了一次性用品市場的成長。隨著對感染預防和控制的日益重視,醫療機構優先使用一次性醫療用品,以盡量減少交叉污染和院內感染的風險。對病人安全的高度關注推動了一次性醫用塑膠的採用,包括注射器、導管、手套和手術單等。其次,不斷擴大的醫療基礎設施,尤其是新興經濟體的醫療基礎設施,推動了對一次性醫用塑膠的需求。隨著醫療保健服務的改善和醫療設施的擴大,對負擔得起且易於獲取的醫療用品的需求不斷成長,導致塑膠製成的一次性醫療產品的消費量增加。此外,一次性醫療塑膠領域受到注塑和擠出等製造技術進步的推動,這些技術使得一次性醫用塑膠的大規模生產成為可能,具有成本效益。
北美洲
美國
加拿大
亞太
中國
日本
印度
韓國
澳洲
印尼
其他
歐洲
德國
法國
英國
義大利
西班牙
俄羅斯
其他
拉丁美洲
巴西
墨西哥
其他
中東和非洲
亞太地區引領市場,佔最大醫用塑膠市場佔有率
該報告還對所有主要區域市場進行了全面分析,其中包括北美(美國和加拿大);歐洲(德國、法國、英國、義大利、西班牙、俄羅斯等);亞太地區(中國、日本、印度、韓國、澳洲、印尼等);拉丁美洲(巴西、墨西哥等);以及中東和非洲。報告稱,亞太地區是醫用塑膠最大的區域市場。
亞太地區人口成長和醫療保健需求不斷成長,推動了醫療器材和設備需求的不斷成長。隨著經濟的發展和醫療保健基礎設施的改善,亞太地區國家對醫用塑膠的需求激增,以支持其醫療保健系統。此外,該地區慢性病的盛行率不斷上升,推動了對醫療干預和治療的需求,從而增加了對醫用塑膠的需求。此外,嚴格的監管標準要求在醫療保健環境中使用安全和無菌材料,這正在影響亞太地區醫用級塑膠的採用,以確保符合國際品質和安全標準。
市場研究報告也對市場競爭格局進行了全面分析。也提供了所有主要公司的詳細資料。醫用塑膠產業的一些主要市場參與者包括阿科瑪公司、巴斯夫、塞拉尼斯公司、科思創公司、陶氏化學公司、杜邦公司、贏創工業公司、埃克森美孚公司、SABIC、索爾維公司、路博潤公司(波克夏海瑟威公司)、Trinseo PLC 等
(請注意,這只是關鍵參與者的部分列表,報告中提供了完整列表。)
醫用塑膠市場的主要參與者正在積極採取各種策略來維持和增強其市場地位。這些策略包括產品創新和開發,以滿足不斷變化的客戶需求和監管要求。該公司正在大力投資研發 (R&D) 活動,以引入能夠提高性能、生物相容性和成本效益的新型材料和技術。此外,策略夥伴關係、合作和併購在主要參與者之間普遍存在,促進了進入新市場、技術和分銷管道的機會。此外,市場參與者正致力於透過地理擴張和市場滲透策略擴大其全球影響力,瞄準醫療基礎設施不斷發展的新興經濟體。此外,永續發展計劃正在吸引主要參與者的關注,越來越重視開發環保和可回收的醫用塑膠,以解決環境問題並符合永續發展的監管趨勢。此外,我們正在對製造能力和供應鏈最佳化進行投資,以提高營運效率並滿足全球對醫用塑膠不斷成長的需求。
2022 年 8 月:科思創推出了具有抗菌特性的突破性醫用級聚碳酸酯樹脂,旨在抑制醫療表面有害細菌的生長。這項創新解決了人們日益關注的院內感染問題,並提高了醫療機構中病患的安全。
2023 年11 月:杜邦公司(NYSE:DD)宣布,杜邦(TM) Liveo (TM) 醫療保健解決方案正在與全球半導體技術領導者意法半導體(STMicroElectronics) 合作,為電子應用領域的客戶提供服務,開發新的智慧型穿戴裝置概念用於遠端生物訊號監測。
The global medical plastics market size reached US$ 27.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 46.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5.8% during 2024-2032. Increasing demand for medical devices and equipment, growing prevalence of chronic diseases, stringent regulatory standards, rising geriatric population, COVID-19 pandemic emphasizing infection prevention, technological advancements, and minimally invasive surgical (MIS) procedures are some of the factors creating a positive outlook for the market.
Major Market Drivers: The medical plastics market share is primarily bolstered by the burgeoning investments in healthcare infrastructure across the world, which further contributes to high demand for protective medical equipment, consequently, more use of medical plastics. In line with this, the aging population in developed countries requires more medical attention, which leads to more consumption of medical plastics used to create both medical devices and packaging, further accelerating the medical plastics market growth. As per the medical plastics market recent developments, technological breakthroughs in medical industry, and the trend for making more devices disposable increased the need for specialized plastics, further bolstering the medical plastics market demand. Additionally, the rise of home-based health services and telemedicine increases the production of plastic components, which is further driving the medical plastics market outlook. Furthermore, due to high standards of sanitation, most equipment used in medical facilities is made of plastic as the material is easy to sanitize and sterile, which is supporting the medical plastics market forecast.
Key Market Trends: The key medical plastics market trends include the increasing adoption of high-performance plastic properties due to their high resistance to chemicals, heat, and impact. High-performance plastics appear fashionable because most medical equipment and other products are indispensable for surgical procedures and other work done in the clinic or hospital. In line with this, the adoption of three-dimensional (3D) printing of compatible medical devices and implants thus increases the demand for such devices, which is further driving the medical plastics market revenue. As per the medical plastics market report, 3D technology now emerges as one of the means on which one can order customization of one's required equipment.
Geographical Trends: As per the medical plastics market overview, the North American region secures the leading position in the global market of medical plastics. This trend results from the well-developed infrastructure of healthcare, major investments into medical technology, and strict regulation that sets high-quality standards for medical plastics. As per the medical plastics market analysis, the region's attention to unique solutions in healthcare, such as wearables and telemedicine, stimulates the use of advanced medical plastics. The strong pharmaceutical sector of North America demands safety and quality in packaging, creating the conditions for increased application of medical-grade plastics.
Competitive Landscape: As per the medical plastics market statistics, some of the key players in the medical plastics market companies include Arkema SA, BASF SE, Celanese Corporation, Covestro AG, The Dow Chemical Company, DuPont de Nemours Inc, Evonik Industries AG, Exxon Mobil Corporation, SABIC, Solvay S.A., The Lubrizol Corporation (Berkshire Hathaway Inc.), Trinseo PLC, etc.
Challenges and Opportunities: The medical plastics market faces several challenges, including the high cost of compliance with stringent regulatory standards, which can inhibit the speed of product development and market entry. Additionally, the environmental impact of non-biodegradable plastics poses a challenge, pressing manufacturers to innovate more sustainable solutions. However, these challenges also present medical plastics market recent opportunities. There is a growing demand for advanced, eco-friendly medical plastics that offer the same or better performance than traditional materials. Opportunities also occur in developing economies where expanding healthcare infrastructure demands increased quantities of medical plastics, which is further accelerating the medical plastics market recent price.
Escalating demand for medical devices
The increasing requirement for medical devices and equipment across the world is a key growth factor for the global medical plastics market.. As health facilities seek to meet the rising patient demand, the demand for plastics-made medical devices grows since they are versatile and relatively affordable and meet stringent regulatory specifications for medical products. From diagnostic equipment to surgical instruments, medical-grade plastics are versatile enough to fit into a variety of applications.
Surging prevalence of chronic diseases
Another major factor contributing to the trend is the rapid rise in chronic conditions, ranging from diabetes and cardiovascular conditions to respiratory disorders. Due to the increasing prevalence of such diseases, medical interventions and therapy are in high demand globally. As a result, various medical equipment, tools, and products made of plastics are needed to support this growing need, which has further surged the demand for medical plastics as they are durable, flexible, and biocompatible, making them perfect for multiple applications in disease control and management.
Stringent regulatory standards
The demand for medical plastics is also driven by the strict regulatory standards on medical devices and products safety and efficacy. Regulatory bodies across the globe provide guidelines for materials used in healthcare applications to ensure that they are of high quality and safe for patient health. Medical grade plastics have properties such as biocompatibility, sterility, and chemical resistance, characteristic of the regulatory requirements. Consequently, as patient safety and infection control receives unprecedented prioritization by healthcare facilities, many prefer medical equipment and devices made of quality plastics that support these priorities.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on material and application.
Polyvinyl Chloride (PVC)
Polypropylene (PP)
Engineering Plastics
Polyethylene (PE)
Polystyrene (PS)
Silicones
Others
Polyvinyl chloride (PVC) represents the leading market segment
The report has provided a detailed breakup and analysis of the market based on the material. This includes polyvinyl chloride (PVC), polypropylene (PP), engineering plastics, polyethylene (PE), polystyrene (PS), silicones, and others. According to the report, polyvinyl chloride (PVC) represented the largest segment.
The polyvinyl chloride (PVC) segment in medical plastics is driven by several key factors, such as the increasing demand for cost-effective and versatile materials in medical device manufacturing propels the growth of PVC usage. PVC offers a balance between affordability and performance, making it an attractive choice for a wide range of medical applications such as tubing, intravenous (IV) bags, and blood transfusion sets. Furthermore, the excellent properties of PVC, including flexibility, durability, and chemical resistance, make it suitable for various medical devices and equipment, driving its adoption across healthcare settings. Additionally, stringent regulatory standards mandating the use of safe and sterile materials in medical applications further boost the demand for PVC, as it meets regulatory requirements effectively. Moreover, the versatility of PVC enables manufacturers to produce a wide range of medical products tailored to specific healthcare needs, catering to diverse patient populations and medical procedures. Apart from this, the COVID-19 pandemic has underscored the importance of PVC in healthcare, particularly in the production of essential medical supplies such as PPE kits and medical packaging, further driving its demand.
Disposables
Drug Delivery Devices
Diagnostic Instruments
Catheters
Surgical Instruments
Others
Disposables represents the leading market segment
The report has provided a detailed breakup and analysis of the market based on the application. This includes disposables, drug delivery devices, diagnostic instruments, catheters, surgical instruments, and others. According to the report, disposables represented the largest segment.
The disposables segment in medical plastics is driven by several key factors, each influencing its growth trajectory significantly, such as the increasing demand for single-use medical products in healthcare settings fuels the growth of the disposables segment. With the rising emphasis on infection prevention and control, healthcare facilities prioritize the use of disposable medical items to minimize the risk of cross-contamination and nosocomial infections. This heightened focus on patient safety drives the adoption of disposable medical plastics, including syringes, catheters, gloves, and surgical drapes, among others. Secondly, the expanding healthcare infrastructure, particularly in emerging economies, drives the demand for disposable medical plastics. As healthcare access improves and medical facilities expand, there is a growing need for affordable and easily accessible medical supplies, leading to increased consumption of disposable medical products made from plastics. Moreover, the disposables segment is propelled by advancements in manufacturing technologies, such as injection molding and extrusion, which enable cost-effective production of disposable medical plastics at scale.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Asia Pacific leads the market, accounting for the largest medical plastics market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific represents the largest regional market for medical plastics.
The Asia Pacific region is driven by the increasing demand for medical devices and equipment, fueled by the region's growing population and rising healthcare needs. With expanding economies and improving healthcare infrastructure, countries in the Asia Pacific are witnessing a surge in demand for medical plastics to support their healthcare systems. Additionally, the prevalence of chronic diseases is on the rise in the region, driving the demand for medical interventions and therapies, thus increasing the need for medical plastics. Furthermore, stringent regulatory standards mandating the use of safe and sterile materials in healthcare settings are influencing the adoption of medical-grade plastics in the Asia Pacific region, ensuring compliance with international quality and safety standards.
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the medical plastics industry include Arkema SA, BASF SE, Celanese Corporation, Covestro AG, The Dow Chemical Company, DuPont de Nemours Inc, Evonik Industries AG, Exxon Mobil Corporation, SABIC, Solvay S.A., The Lubrizol Corporation (Berkshire Hathaway Inc.), Trinseo PLC, etc.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
Key players in the medical plastics market are actively engaged in various strategies to maintain and enhance their market positions. These strategies include product innovation and development to meet evolving customer needs and regulatory requirements. Companies are investing significantly in research and development (R&D) activities to introduce novel materials and technologies that offer improved performance, biocompatibility, and cost-effectiveness. Moreover, strategic partnerships, collaborations, and mergers and acquisitions are prevalent among key players, facilitating access to new markets, technologies, and distribution channels. Additionally, market players are focusing on expanding their global presence through geographical expansion and market penetration strategies, targeting emerging economies with growing healthcare infrastructures. Furthermore, sustainability initiatives are gaining traction among key players, with a growing emphasis on developing eco-friendly and recyclable medical plastics to address environmental concerns and align with regulatory trends towards sustainability. Moreover, investments in manufacturing capabilities and supply chain optimization are being made to enhance operational efficiency and meet the increasing demand for medical plastics globally.
In August 2022: Covestro introduced a breakthrough medical-grade polycarbonate resin with antimicrobial properties, designed to inhibit the growth of harmful bacteria on medical surfaces. This innovation addresses the growing concern of hospital-acquired infections and enhances patient safety in healthcare settings.
In November 2023: DuPont (NYSE:DD) announced that DuPont(TM) Liveo(TM) Healthcare Solutions is collaborating with STMicroelectronics, a global leader in semiconductor technology serving customers across the spectrum of electronics applications, to develop a new smart wearable device concept for remote biosignal-monitoring.